ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
BioStem Technologies, Inc.
3.92
+0.3800
10.73%
成交量：
11.30萬
成交額：
42.29萬
市值：
6,990.10萬
市盈率：
-2.35
高：
3.95
開：
3.77
低：
3.55
收：
3.54
52周最高：
8.40
52周最低：
2.25
股本：
1,783.19萬
流通股本：
1,404.21萬
量比：
1.21
換手率：
0.80%
股息：
- -
股息率：
- -
每股收益(TTM):
-1.6713
每股收益(LYR):
-0.3934
淨資產收益率：
-74.74%
總資產收益率：
-18.07%
市淨率：
2.53
市盈率(LYR):
-9.96
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
BioStem Technologies, Inc.
交易所：
NASDAQ
成立時間：
2006
員工人數：
73
公司地址：
4901 Northwest 17th Way,Suite 606,Fort Lauderdale,Florida,United States
官網：
http://www.biostemtech.com
郵編：
33309
電話：
954 380 8342
傳真：
- -
簡介：
BioStem Technologies, Inc.於2006年7月7日在猶他州成立並於2009年3月2日在佛羅里達州重新註冊。BioStem Technologies, Inc.是一家再生醫學公司，專註於開發和商業化基於圍產期組織的療法，用於高級傷口護理和外科手術。公司利用專有的加工技術，充分發揮圍產期組織的天然特性，提供旨在支持組織修復和再生的解決方案。其產品組合主要包括胎盤來源的同種異體移植片，涵蓋乾式和冷凍保存兩種選擇，這些移植片可作為保護屏障，在各種臨床環境中支持人體自身的癒合過程。公司的技術旨在解決糖尿病足潰瘍、靜脈性腿部潰瘍、壓瘡、創傷性傷口和手術切口等疾病，以促進更快的癒合並降低整體治療成本。這些技術的臨床益處已在前瞻性對照臨床試驗和回顧性數據分析中得到評估，結果表明，與標準治療相比，這些技術能夠改善患者的治療效果。公司已通過戰略收購擴展了產品組合，並計劃繼續開發互補的再生療法，以滿足傷口管理和外科癒合方面尚未滿足的需求。
董事
名稱
職位
Jason Matuszewski
Chairman of the Board and Chief Executive Officer and Director
Andrew Van Vurst
Chief Operating Officer and Director
Jodi Ungrodt
Independent Director
Kenneth Warrington
Independent Director
Mark Glickman
Independent Director
Rayna Hannaway
Independent Director
Steven Sonenreich
Independent Director
股東
名稱
職位
Jason Matuszewski
Chairman of the Board and Chief Executive Officer and Director
Andrew Van Vurst
Chief Operating Officer and Director
Brandon Poe
Chief Financial Officer
Barry Hassett
Chief Commercial Officer
Katherine Gorrell
Chief Legal & Compliance Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/BSEM/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BSEM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","market":"US","secType":"STK","nameCN":"BioStem Technologies, Inc.","latestPrice":3.92,"timestamp":1787601600000,"preClose":3.54,"halted":0,"volume":112957,"delay":0,"changeRate":0.10734463276836155,"floatShares":14042148,"shares":17831900,"eps":-1.671347,"marketStatus":"盤前交易","change":0.38,"latestTime":"08-25 04:30:17 EDT","open":3.77,"high":3.95,"low":3.55,"amount":422880.17073899996,"amplitude":0.112994,"askPrice":4.89,"askSize":100,"bidPrice":1.83,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.671347,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":3.92,"postHourTrading":{"tag":"盘后","latestPrice":3.86,"preClose":3.92,"latestTime":"19:30 EDT","volume":6985,"amount":26914.6529,"timestamp":1787614203210,"change":-0.06,"changeRate":-0.015306,"amplitude":0.028061},"volumeRatio":1.2060994195233243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BSEM\",,,,,undefined,":{"symbol":"BSEM","floatShares":14042148,"roa":"-18.07%","roe":"-74.74%","lyrEps":-0.393388,"volumeRatio":1.2060994195233243,"shares":17831900,"dividePrice":0,"high":3.95,"amplitude":0.112994,"preClose":3.54,"low":3.55,"week52Low":2.251,"pbRate":"2.53","psRate":"2.02","week52High":8.4,"institutionHeld":0,"latestPrice":3.92,"eps":-1.671347,"divideRate":0,"volume":112957,"delay":0,"ttmEps":-1.671347,"open":3.77,"prevYearClose":3.81,"prevWeekClose":3.54,"prevMonthClose":3.3142,"prevQuarterClose":3.3,"fiveDayClose":3,"twentyDayClose":3.82,"sixtyDayClose":3.9125},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BSEM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"BSEM","fiscalQuarterEnding":"2026/06","expectedEps":-0.5,"name":null,"time":"盤後","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.52},{"date":"2026-05-14","symbol":"BSEM","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778788800000,"name":null,"time":"盤後","dateTimestamp":1778731200000,"actualEps":null},{"date":"2026-03-24","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774339200000,"name":null,"time":"","dateTimestamp":1774324800000,"actualEps":null},{"date":"2025-11-13","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763024400000,"name":null,"time":"","dateTimestamp":1763010000000,"actualEps":null},{"date":"2025-08-14","symbol":"BSEM","type":"earning","reportTimeType":"","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755158400000,"name":null,"time":"","dateTimestamp":1755144000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BSEM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BSEM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1778299200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BSEM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BSEM","date":"2026-08-21","current":-2.345414,"percent":0.5,"low":-3.757423,"twenty":-3.470255,"median":-2.321824,"eighty":-1.987431,"high":-1.892791,"avg":-2.677618,"sd":0.700647,"marketCap":65686053},"quantilePoints":[{"date":"2026-08-06","current":-3.060802,"twenty":-3.060802,"median":-3.060802,"eighty":-3.060802,"marketCap":59100221},{"date":"2026-08-14","current":-1.982708,"twenty":-3.488616,"median":-3.39222,"eighty":-3.060802,"marketCap":54952215},{"date":"2026-08-21","current":-2.321824,"twenty":-3.470255,"median":-2.321824,"eighty":-1.987431,"marketCap":65686053}],"updateTime":1787646617466},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":245319,"yearFounded":2006,"employeeNum":73,"address":"4901 Northwest 17th Way,Suite 606,Fort Lauderdale,Florida,United States","zipCode":"33309","officePhone":"954 380 8342","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.biostemtech.com","stockEarnings":[{"period":"1week","weight":0.3067},{"period":"1month","weight":-0.0224},{"period":"3month","weight":0.0026},{"period":"6month","weight":-0.3062},{"period":"1year","weight":-0.3241},{"period":"ytd","weight":0.0289}],"compareEarnings":[{"period":"1week","weight":-0.0119},{"period":"1month","weight":0.0332},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1014},{"period":"1year","weight":0.1831},{"period":"ytd","weight":0.1196}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"BioStem Technologies, Inc.於2006年7月7日在猶他州成立並於2009年3月2日在佛羅里達州重新註冊。BioStem Technologies, Inc.是一家再生醫學公司，專註於開發和商業化基於圍產期組織的療法，用於高級傷口護理和外科手術。公司利用專有的加工技術，充分發揮圍產期組織的天然特性，提供旨在支持組織修復和再生的解決方案。其產品組合主要包括胎盤來源的同種異體移植片，涵蓋乾式和冷凍保存兩種選擇，這些移植片可作為保護屏障，在各種臨床環境中支持人體自身的癒合過程。公司的技術旨在解決糖尿病足潰瘍、靜脈性腿部潰瘍、壓瘡、創傷性傷口和手術切口等疾病，以促進更快的癒合並降低整體治療成本。這些技術的臨床益處已在前瞻性對照臨床試驗和回顧性數據分析中得到評估，結果表明，與標準治療相比，這些技術能夠改善患者的治療效果。公司已通過戰略收購擴展了產品組合，並計劃繼續開發互補的再生療法，以滿足傷口管理和外科癒合方面尚未滿足的需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.131737},{"month":2,"riseRate":0.25,"avgChangeRate":-0.090412},{"month":3,"riseRate":0.375,"avgChangeRate":0.006528},{"month":4,"riseRate":0.5,"avgChangeRate":0.172724},{"month":5,"riseRate":0.111111,"avgChangeRate":-0.12593},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.09256},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.009279},{"month":8,"riseRate":0.555556,"avgChangeRate":0.013284},{"month":9,"riseRate":0.625,"avgChangeRate":0.10561},{"month":10,"riseRate":0.375,"avgChangeRate":0.048985},{"month":11,"riseRate":0.5,"avgChangeRate":0.227776},{"month":12,"riseRate":0.25,"avgChangeRate":0.022544}],"exchange":"NASDAQ","name":"BioStem Technologies, Inc.","nameEN":"BioStem Technologies, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"BSEM\",market:\"US\",,,undefined,":{"directors":[{"name":"Jason Matuszewski","position":"Chairman of the Board and Chief Executive Officer and Director"},{"name":"Andrew Van Vurst","position":"Chief Operating Officer and Director"},{"name":"Jodi Ungrodt","position":"Independent Director"},{"name":"Kenneth Warrington","position":"Independent Director"},{"name":"Mark Glickman","position":"Independent Director"},{"name":"Rayna Hannaway","position":"Independent Director"},{"name":"Steven Sonenreich","position":"Independent Director"}],"executives":[{"name":"Jason Matuszewski","position":"Chairman of the Board and Chief Executive Officer and Director"},{"name":"Andrew Van Vurst","position":"Chief Operating Officer and Director"},{"name":"Brandon Poe","position":"Chief Financial Officer"},{"name":"Barry Hassett","position":"Chief Commercial Officer"},{"name":"Katherine Gorrell","position":"Chief Legal & Compliance Officer"}]}}}